Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery

A comparative study

Galina Leyvi, Ilya Zhuravlev, Asuquo Inyang, Joselito Vinluan, Sujatha Ramachandran, Ellen J. Lehning, John D. Wasnick

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: Activated coagulation times (ACTs) are widely used for monitoring anticoagulation during cardiac surgery. Significant variability of this test is well known. Variability in test results was studied, which may arise from the sample drawing site. Design: Prospective study. Setting: University hospital. Participants: Sixty-five patients scheduled for surgery requiring cardiopulmonary bypass were enrolled in the study. Intervention: ACTs were assessed using the Hemochron 801 ACT machine. Samples were collected (1) baseline I from the arterial catheter before anesthetic induction, (2) baseline II from the arterial and venous collection sites after pulmonary artery catheterization, (3) after heparin administration, (4) 10 minutes after blood collection number 3, and (5) after protamine administration. Measurements and main results: At the baseline II, the ACT measures using venous blood were significantly higher than that obtained using an arterial sample (p = 0.001). There was no significant difference in ACT measures obtained using either arterial or venous blood samples at the other time points. After heparin administration, the ACT variability in individual patients was quite striking, with ranges of up to 600 seconds in repeated measures. Conclusion: During the period of systemic anticoagulation, there is great individual variability between ACT measures obtained from venous and arterial samples. Further studies are required to analyze the cause of differences at the baseline and the source of variable coagulation times after heparin.

Original languageEnglish (US)
Pages (from-to)573-580
Number of pages8
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume18
Issue number5
DOIs
StatePublished - Oct 2004

Fingerprint

Thoracic Surgery
Heparin
Swan-Ganz Catheterization
Protamines
Cardiopulmonary Bypass
Anesthetics
Catheters
Prospective Studies

Keywords

  • activated coagulation time
  • cardiopulmonary bypass
  • coagulation
  • heparin
  • protamine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery : A comparative study. / Leyvi, Galina; Zhuravlev, Ilya; Inyang, Asuquo; Vinluan, Joselito; Ramachandran, Sujatha; Lehning, Ellen J.; Wasnick, John D.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 18, No. 5, 10.2004, p. 573-580.

Research output: Contribution to journalArticle

Leyvi, Galina ; Zhuravlev, Ilya ; Inyang, Asuquo ; Vinluan, Joselito ; Ramachandran, Sujatha ; Lehning, Ellen J. ; Wasnick, John D. / Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery : A comparative study. In: Journal of Cardiothoracic and Vascular Anesthesia. 2004 ; Vol. 18, No. 5. pp. 573-580.
@article{2e0217e6aeed4d5fbcbcf3ae4d478ddd,
title = "Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: A comparative study",
abstract = "Objective: Activated coagulation times (ACTs) are widely used for monitoring anticoagulation during cardiac surgery. Significant variability of this test is well known. Variability in test results was studied, which may arise from the sample drawing site. Design: Prospective study. Setting: University hospital. Participants: Sixty-five patients scheduled for surgery requiring cardiopulmonary bypass were enrolled in the study. Intervention: ACTs were assessed using the Hemochron 801 ACT machine. Samples were collected (1) baseline I from the arterial catheter before anesthetic induction, (2) baseline II from the arterial and venous collection sites after pulmonary artery catheterization, (3) after heparin administration, (4) 10 minutes after blood collection number 3, and (5) after protamine administration. Measurements and main results: At the baseline II, the ACT measures using venous blood were significantly higher than that obtained using an arterial sample (p = 0.001). There was no significant difference in ACT measures obtained using either arterial or venous blood samples at the other time points. After heparin administration, the ACT variability in individual patients was quite striking, with ranges of up to 600 seconds in repeated measures. Conclusion: During the period of systemic anticoagulation, there is great individual variability between ACT measures obtained from venous and arterial samples. Further studies are required to analyze the cause of differences at the baseline and the source of variable coagulation times after heparin.",
keywords = "activated coagulation time, cardiopulmonary bypass, coagulation, heparin, protamine",
author = "Galina Leyvi and Ilya Zhuravlev and Asuquo Inyang and Joselito Vinluan and Sujatha Ramachandran and Lehning, {Ellen J.} and Wasnick, {John D.}",
year = "2004",
month = "10",
doi = "10.1053/j.jvca.2004.07.006",
language = "English (US)",
volume = "18",
pages = "573--580",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery

T2 - A comparative study

AU - Leyvi, Galina

AU - Zhuravlev, Ilya

AU - Inyang, Asuquo

AU - Vinluan, Joselito

AU - Ramachandran, Sujatha

AU - Lehning, Ellen J.

AU - Wasnick, John D.

PY - 2004/10

Y1 - 2004/10

N2 - Objective: Activated coagulation times (ACTs) are widely used for monitoring anticoagulation during cardiac surgery. Significant variability of this test is well known. Variability in test results was studied, which may arise from the sample drawing site. Design: Prospective study. Setting: University hospital. Participants: Sixty-five patients scheduled for surgery requiring cardiopulmonary bypass were enrolled in the study. Intervention: ACTs were assessed using the Hemochron 801 ACT machine. Samples were collected (1) baseline I from the arterial catheter before anesthetic induction, (2) baseline II from the arterial and venous collection sites after pulmonary artery catheterization, (3) after heparin administration, (4) 10 minutes after blood collection number 3, and (5) after protamine administration. Measurements and main results: At the baseline II, the ACT measures using venous blood were significantly higher than that obtained using an arterial sample (p = 0.001). There was no significant difference in ACT measures obtained using either arterial or venous blood samples at the other time points. After heparin administration, the ACT variability in individual patients was quite striking, with ranges of up to 600 seconds in repeated measures. Conclusion: During the period of systemic anticoagulation, there is great individual variability between ACT measures obtained from venous and arterial samples. Further studies are required to analyze the cause of differences at the baseline and the source of variable coagulation times after heparin.

AB - Objective: Activated coagulation times (ACTs) are widely used for monitoring anticoagulation during cardiac surgery. Significant variability of this test is well known. Variability in test results was studied, which may arise from the sample drawing site. Design: Prospective study. Setting: University hospital. Participants: Sixty-five patients scheduled for surgery requiring cardiopulmonary bypass were enrolled in the study. Intervention: ACTs were assessed using the Hemochron 801 ACT machine. Samples were collected (1) baseline I from the arterial catheter before anesthetic induction, (2) baseline II from the arterial and venous collection sites after pulmonary artery catheterization, (3) after heparin administration, (4) 10 minutes after blood collection number 3, and (5) after protamine administration. Measurements and main results: At the baseline II, the ACT measures using venous blood were significantly higher than that obtained using an arterial sample (p = 0.001). There was no significant difference in ACT measures obtained using either arterial or venous blood samples at the other time points. After heparin administration, the ACT variability in individual patients was quite striking, with ranges of up to 600 seconds in repeated measures. Conclusion: During the period of systemic anticoagulation, there is great individual variability between ACT measures obtained from venous and arterial samples. Further studies are required to analyze the cause of differences at the baseline and the source of variable coagulation times after heparin.

KW - activated coagulation time

KW - cardiopulmonary bypass

KW - coagulation

KW - heparin

KW - protamine

UR - http://www.scopus.com/inward/record.url?scp=5644273929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644273929&partnerID=8YFLogxK

U2 - 10.1053/j.jvca.2004.07.006

DO - 10.1053/j.jvca.2004.07.006

M3 - Article

VL - 18

SP - 573

EP - 580

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 5

ER -